S7 Sciences
🇺🇸⌄
21+

Restricted research comparison

Before entering S7 Sciences

Please confirm both statements below. Access is limited to adults who understand the strict research-use restriction applied to the third-party product listings compared on this site.

Required confirmations
I cannot confirm — exit site

Important safety information: S7 Sciences is an affiliate comparison site, not a seller or medical provider. Linked products are not intended for injection or other administration. Please review the complete Terms of Use.

Independent affiliate comparison · Research use only · Not medical advice
S7 Sciences
ProductsOffersCalculatorCOAResourcesSocial MediaAboutContactAffiliatesInternational Vendors
Comparison Cart0
Comparison cart
0 items

No products added yet.

Open full comparison cart
🇺🇸⌄

The selected language applies across the complete S7 Sciences site. Exact product names, vendor names, strengths, prices, coupon codes, source titles, authors, quotations, and destination links remain unchanged.

S7 research desk

Fresh perspectives. Research made clearer.

Explore our latest articles, followed by five original S7 research guides. The five guides translate official labeling and peer-reviewed research into plain language, with new editions every Wednesday.

Five research guides updated weeklyWednesday morningsSources shown with every guide

Featured article

Build the Metabolism. Build the Muscle. Cut the Fat?

Exploring the connections between energy, muscle, and fat metabolism through MOTS-c, SLU-PP-332 and AOD-9604 research.

September 11, 20269 min read
Read on S7 Sciences

Latest reading

Read the complete article here.

Start with the latest Soro-powered articles. Our five weekly guides follow, each crediting the original authors and publication and linking to the complete sources and supporting evidence.

01
Latest articlesPowered by Soro

From the S7 journal.

Browse new articles as they are published through our Soro feed.

Loading the latest articles…

02
Men’s health evidence3 min read

Featured articleSemaglutide improved sperm morphology in obese men with type 2 diabetes mellitus and functional hypogonadism

A small randomized study raises a reproductive-health question without establishing a fertility treatment.

A change in a semen measurement is an interesting research signal, not proof of improved chances of pregnancy.

Updated September 9, 20263 min readSources shown with every article
Read on S7 Sciences
03
Women’s health evidence3 min read

Featured articleEffects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial

What a controlled brain-imaging experiment contributes to research on low sexual desire—and what it cannot establish.

An experimental brain response can help researchers form a hypothesis without proving an effective long-term treatment.

Updated September 9, 20263 min readSources shown with every article
Read on S7 Sciences
04
Lab math3 min read

Featured articleGuide for the Use of the International System of Units (SI)

An arithmetic-only guide to three different quantities that can hide behind the word concentration.

A number is not a complete concentration: identify the substance, the numerator and the denominator before comparing values.

Updated September 9, 20263 min readSources shown with every article
Read on S7 Sciences
05
Evidence guide3 min read

Featured articleTriple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial

A focused reading of retatrutide’s phase-two obesity trial and the limits of borrowing evidence across catalog compounds.

A trial supports claims about its tested product, population and endpoints—not every benefit attached to a compound online.

Updated September 9, 20263 min readSources shown with every article
Read on S7 Sciences
06
Safety and duration3 min read

Featured articleTirzepatide for Obesity Treatment and Diabetes Prevention

What a 176-week trial adds to long-term evidence, and why its observation period is not a reusable schedule.

Long follow-up helps answer a specific clinical question; it does not validate a generic on-and-off peptide cycle.

Updated September 9, 20263 min readSources shown with every article
Read on S7 Sciences

Soro archive

Previous Soro articles.

Rolling archive

Previous weekly editions.

Editions remain available here for 3 months, then are removed automatically so older evidence is not mistaken for the current review.

Featured sources are listed once. Choose a dated edition to read that week's S7 article and see the sources added in that update.

Effects of Kisspeptin on Sexual Brain Processing and Penile Tumescence in Men With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial

JAMA Network Open via PubMed

Published September 2, 2026
Previous weekly editions.
  • Published September 2, 2026Text and sources unchanged
  • Published August 26, 2026Evidence updated

    Sources added in this edition

    • Chronic Subcutaneous Kisspeptin-10 Stimulates Gonadotropin Secretion for 12 Days in Healthy Men
  • Published August 19, 2026Text and sources unchanged
  • Published August 12, 2026Evidence updated

    Sources added in this edition

    • Dynamic modulation of LH secretion by continuous kisspeptin infusion in healthy men
  • Published August 7, 2026Archived edition

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials

Obstetrics & Gynecology via PubMed

Published September 2, 2026
Previous weekly editions.
  • Published September 2, 2026Text and sources unchanged
  • Published August 26, 2026Text and sources unchanged
  • Published August 19, 2026Text and sources unchanged
  • Published August 12, 2026Text and sources unchanged
  • Published August 7, 2026Archived edition

Bacteriostatic Water for Injection, USP labeling

DailyMed / U.S. National Library of Medicine

Published September 2, 2026
Previous weekly editions.
  • Published September 2, 2026Text and sources unchanged
  • Published August 26, 2026Text and sources unchanged
  • Published August 19, 2026Text and sources unchanged
  • Published August 12, 2026Text and sources unchanged
  • Published August 5, 2026Text and sources unchanged
  • Published August 4, 2026Archived edition

Two-year effects of semaglutide in adults with overweight or obesity (STEP 5)

Nature Medicine via PubMed

Published September 2, 2026
Previous weekly editions.
  • Published September 2, 2026Evidence updated

    Sources added in this edition

    • FDA reminds compounders not to use dietary supplement grade glutathione for injectables
  • Published August 26, 2026Evidence updated

    Sources added in this edition

    • Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels
  • Published August 19, 2026Evidence updated

    Sources added in this edition

    • Glutathione infusion before primary percutaneous coronary intervention: a randomised controlled pilot study
    • Victory Medical Center Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels
  • Published August 12, 2026Evidence updated

    Sources added in this edition

    • Efficacy and safety of retatrutide in people with type 2 diabetes (TRANSCEND-T2D-1): a randomized phase 3 trial
    • FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
  • Published August 5, 2026Text and sources unchanged
  • Published August 4, 2026Archived edition

Continued treatment with tirzepatide for maintenance of weight reduction (SURMOUNT-4)

JAMA via PubMed

Published September 2, 2026
Previous weekly editions.
  • Published September 2, 2026Text and sources unchanged
  • Published August 26, 2026Evidence updated

    Sources added in this edition

    • Chronic Subcutaneous Kisspeptin-10 Stimulates Gonadotropin Secretion for 12 Days in Healthy Men
  • Published August 19, 2026Text and sources unchanged
  • Published August 12, 2026Evidence updated

    Sources added in this edition

    • Efficacy and safety of retatrutide in people with type 2 diabetes (TRANSCEND-T2D-1): a randomized phase 3 trial
    • FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
  • Published August 5, 2026Text and sources unchanged
  • Published August 4, 2026Archived edition

Important boundary

Research education is not medical advice.

Articles describe published evidence and its limits. They do not provide dosing, administration, treatment, or cycling instructions. Consult a licensed physician for medical decisions.

S7 Sciences

An independent price and documentation index for research peptide listings from third-party vendors.

A Sunset 7 Company
@s7.sciences on TikTok

Navigate

ProductsOffersComparison CartConcentration CalculatorCOAResourcesSocial MediaAboutContactAffiliatesInternational Vendors

Information

FAQTermsPrivacyDocumentationVendor & Lab Locationssupport@s7sciences.com

Legal and research-use notice

S7 Sciences does not manufacture, sell, process payment for, or fulfill the linked products. Purchases are completed directly with independent third-party vendors under their own terms and policies.

S7 Sciences may earn a commission from purchases made through clearly labeled links. Vendor prices and documents can change; verify the final listing, lot, COA, shipping, and terms before purchasing.

As an Amazon Associate I earn from qualifying purchases.

Linked materials are presented for laboratory research reference only—not human or veterinary use. This site does not provide medical advice. Please consult a licensed physician before considering or beginning a medical-grade peptide program. Nothing here is dosing guidance or a statement of safety, efficacy, or sterility.

© 2026 S7 SciencesAffiliate relationships disclosed · Prices checked September 10, 2026